Endothelium-derived contracting factor in carotid artery of hypertensive Dahl rats

Hypertension

Volumn 34, Issue 1, 1999, Pages 39-43

  Zhou, Ming Sheng ^b   Nishida, Yasuhiro ^b   Chen, Qing Hui ^b   Kosaka, Hiroaki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Acetylcholine; Arteries; Endothelium derived relaxing factor; Hypertension, sodium dependent; Prostaglandin; Rats, Dahl; Receptors; Thromboxane

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLCHOLINE; ATROPINE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; INDOMETACIN; ONO 8809; OZAGREL; SODIUM CHLORIDE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CAROTID ARTERY; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SALT INTAKE; VASOCONSTRICTION;

EID: 0032793665     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.39     Document Type: Article

References (25)

1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
2. Palmer RMJ, Ferrigo AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-525.
3. Nishimura Y, Hsui H, Kurahashi K, Suzuki A. Endothelium-dependent contraction induced by acetylcholine in isolated rat renal arteries. Eur J Pharmacol. 1995;275:217-221.
4. Rapoport R, Williams SP. Role of prostaglandins in acetylcholine-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1996;28:64-75.
5. 2 as an endothelium-derived contracting factor in diabetic state. Diabetes. 1993;42: 1246-52.
6. 2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension. 1992;19:795-798.
7. Lucher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
8. A receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension. 1998;31:499-504.
9. Nishida Y, Ding J, Zhou MS, Chen QH, Murakami H, Wu XZ, Kosaka H. Impaired NO release causes vascular hyper-responsiveness to norepinephrine in hypertensive Dahl rats. J Hypertens. 1998;16:1611-1618.
10. Fortes F, Nigro D, Scivoletto R, Carvalho MHC. Indirect evidence for an endothelium-derived contracting factor released in arterioles of deoxycorticosterone acetate salt hypertensive rats. J Hypertens. 1990;8: 1043-1048.
11. Makynen H, Kahonen M, Wu X Arvola P, Porsti I. Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation. Circulation. 1996;93:1000-1008.
12. Zhou MS, Nishida Y, Chen QH, Murakami H, Hosomi H, Kosaka H. Is a hypertensinogenic factor present in the kidney of hypertensive Dahl rats? Clin Exp Pharmarcol Physiol. 1998;25:800-805.
13. Iwama Y, Kato T, Muramatsu M, Asano H, Shimizu K, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T, Satake T. Correlation with blood pressure of the acetylcholine-induced endothelium-derived contracting factor in the rat aorta. Hypertension. 1992;19:362-332.
14. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta. Hypertension. 1992;19:442-445.
15. 3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol. 1994;112:519-524.
16. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29:274-279.
17. 2 in the SHR aorta. Circ Res. 1995;76:1003-1010.
18. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 1990;15:457-481.
19. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension. 1987;9:157-163.
20. Gauthier-Rein KM, Rusch NJ. Distinct endothelial impairment in coronary microvessels from hypertensive Dahl rats. Hypertension. 1998;31: 328-334.
21. 2 synthetase inhibitor. Eur J Pharmacol. 1985; 109:135-144.
22. 2 blockade in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1993;20:679-687.
23. Yamashida W, Ito Y, Weiss MA, Ooi BS, Pollak VE. A thromboxane synthetase antagonist ameliorates progressive renal disease of Dahl-S rats. Kidney Int. 1988;33:77-83.
24. Gomi T, Ikeda T, Kosugi T, Shibuya Y, Sakurai J. Protective effect of thromboxane synthetase inhibitor on hypertensive renal damage in Dahl salt-sensitive rats. Clin Exp Pharmacol Physiol. 1995;22(suppl): S371-S373.
25. Luscher TF. The endothelium: target and promoter of hypertension? Hypertension. 1990;15:482-485.